日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Roles of Interferon Regulatory Factor 1 in Tumor Progression and Regression: Two Sides of a Coin

干扰素调节因子1在肿瘤进展和消退中的作用:一枚硬币的两面

Perevalova, Alina M; Gulyaeva, Lyudmila F; Pustylnyak, Vladimir O

Smoking-Mediated miR-301a/IRF1 Axis Controlling Immunotherapy Response in Lung Squamous Cell Carcinoma Revealed by Bioinformatic Analysis

生物信息学分析揭示吸烟介导的miR-301a/IRF1轴调控肺鳞状细胞癌的免疫治疗反应

Perevalova, Alina M; Kononchuk, Vladislav V; Kalinina, Tatiana S; Kozlov, Vadim V; Gulyaeva, Lyudmila F; Pustylnyak, Vladimir O

Mechanistic Insights of hsa-mir-301a Regulation by Tobacco Smoke in Lung Squamous Cell Carcinoma: Evidence From Bioinformatics Analysis

烟草烟雾调控肺鳞状细胞癌中hsa-mir-301a表达的机制研究:生物信息学分析的证据

Pustylnyak, Vladimir O; Perevalova, Alina M; Gulyaeva, Lyudmila F

Tumor suppressor PTEN regulation by tobacco smoke in lung squamous-cell carcinoma based on bioinformatics analysis

基于生物信息学分析的烟草烟雾对肺鳞状细胞癌中抑癌基因PTEN的调控作用

Pustylnyak, Vladimir O; Alekseenok, Efim Y; Perevalova, Alina M; Kozlov, Vadim V; Gulyaeva, Lyudmila F

miRNA expression and interaction with the 3'UTR of FMR1 in FRAXopathy pathogenesis

miRNA 表达及其与 FMR1 3'UTR 的相互作用在 FRAXopathy 发病机制中的作用

Alexander A Dolskiy, Andrey A Yarushkin, Irina V Grishchenko, Natalya A Lemskaya, Alexey V Pindyurin, Lidiya V Boldyreva, Vladimir O Pustylnyak, Dmitry V Yudkin

Promotion of liver growth by CAR is accompanied by Akt pathway activation and FoxM1-Nedd4-mediated repression of PTEN

CAR 促进肝脏生长伴随着 Akt 通路激活和 FoxM1-Nedd4 介导的 PTEN 抑制

Andrei A Yarushkin, Mark E Mazin, Yuliya A Pustylnyak, Elena A Prokopyeva, Vladimir O Pustylnyak

Increased expression of miR-155 and miR-222 is associated with lymph node positive status

miR-155 和 miR-222 表达增加与淋巴结阳性状态相关

Chernyy, Vladimir; Pustylnyak, Vladimir; Kozlov, Vadim; Gulyaeva, Lyudmila

Inhibitors of Histone Deacetylases Are Weak Activators of the FMR1 Gene in Fragile X Syndrome Cell Lines

组蛋白去乙酰化酶抑制剂是脆性 X 综合征细胞系中 FMR1 基因的弱激活剂

Alexander A Dolskiy, Vladimir O Pustylnyak, Andrey A Yarushkin, Natalya A Lemskaya, Dmitry V Yudkin

The constitutive androstane receptor activator 4-[(4R,6R)-4,6-diphenyl-1,3-dioxan-2-yl]-N,N-dimethylaniline inhibits the gluconeogenic genes PEPCK and G6Pase through the suppression of HNF4α and FOXO1 transcriptional activity

组成型雄烷受体激活剂4-[(4R,6R)-4,6-二苯基-1,3-二氧杂环己烷-2-基]-N,N-二甲基苯胺通过抑制HNF4α和FOXO1的转录活性来抑制糖异生基因PEPCK和G6Pase的表达。

Yarushkin, A A; Kachaylo, E M; Pustylnyak, V O

A Comparison of the Dynamics of S100B, S100A1, and S100A6 mRNA Expression in Hippocampal CA1 Area of Rats during Long-Term Potentiation and after Low-Frequency Stimulation

大鼠海马CA1区S100B、S100A1和S100A6 mRNA表达在长期增强作用和低频刺激后的动态变化比较

Lisachev, Pavel D; Shtark, Mark B; Sokolova, Olga O; Pustylnyak, Vladimir O; Salakhutdinova, Mary Yu; Epstein, Oleg I